Cell	B-Cellular_component
surface	I-Cellular_component
binding	O
characteristics	O
correlate	O
with	O
consensus	O
type	O
I	O
interferon	O
enhanced	O
activity	O
.	O

The	O
binding	O
characteristics	O
of	O
a	O
genetically	O
engineered	O
consensus	O
interferon	O
with	O
unusually	O
high	O
biologic	O
activity	O
were	O
compared	O
to	O
the	O
characteristics	O
of	O
recombinant	O
interferon	O
-	O
alpha	O
2	O
.	O

Both	O
interferon	O
-	O
alpha	O
2	O
and	O
the	O
consensus	O
interferon	O
produced	O
typical	O
biphasic	O
Scatchard	O
plots	O
,	O
indicating	O
multiple	O
independent	O
binding	O
sites	O
.	O

The	O
consensus	O
interferon	O
,	O
which	O
exhibited	O
a	O
biologic	O
potency	O
more	O
than	O
10	O
-	O
fold	O
greater	O
than	O
all	O
other	O
type	O
I	O
interferons	O
,	O
also	O
exhibited	O
binding	O
site	O
affinities	O
greater	O
than	O
those	O
for	O
IFN	O
-	O
alpha	O
2b	O
.	O

In	O
addition	O
,	O
a	O
larger	O
number	O
of	O
high	O
,	O
and	O
low	O
-	O
affinity	O
cell	B-Cellular_component
surface	I-Cellular_component
sites	O
were	O
recognized	O
by	O
the	O
consensus	O
interferon	O
,	O
resulting	O
in	O
equivalent	O
numbers	O
of	O
sites	O
at	O
reduced	O
molar	O
concentrations	O
compared	O
to	O
IFN	O
-	O
a2b	O
.	O

Thus	O
,	O
at	O
any	O
given	O
biologic	O
activity	O
,	O
similar	O
numbers	O
of	O
sites	O
were	O
bound	O
by	O
the	O
consensus	O
interferon	O
and	O
IFN	O
-	O
alpha	O
2	O
,	O
despite	O
differences	O
in	O
their	O
molar	O
concentrations	O
.	O

No	O
differences	O
in	O
internalization	O
kinetics	O
were	O
identified	O
between	O
the	O
two	O
interferons	O
,	O
indicating	O
that	O
the	O
differences	O
in	O
cell	B-Cellular_component
surface	I-Cellular_component
binding	O
may	O
be	O
sufficient	O
to	O
produce	O
the	O
differences	O
in	O
biologic	O
activity	O
.	O

